Get the latest RA - Railamerica Incorporated stock market performance data and financial news.
Rigel's oral medicine, R788, significantly improved the symptoms of rheumatoid arthritis patients in a study compared with a placebo, but as in previous studies high blood pressure emerged as a leading side effect.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10538484/1/rigels-r788-drug-improves-ra-symptoms.html
The weakened economy is causing rheumatoid arthritis patients to put off or delay treatment with expensive injectable drugs and pressuring the leading market players.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10483722/1/ra-patients-choose-pain-over-poverty-survey.html
New data for Rigel's rheumatoid arthritis pill could ease safety fears and open doors for a lucrative deal.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10515499/1/new-ra-data-could-be-magic-pill-for-rigel.html
Article about Rigel's R788 Drug Improves RA Symptoms on page 1 including
related articles and blogs. TheStreet is the source for ...
http://www.thestreet.com/p/newsanalysis/biotech/10538484.html
Article about Rigel's R788 Drug Improves RA Symptoms on page 2 including related
articles and blogs. ... Rigel's R788 Drug Improves RA Symptoms Page 2. ...
http://www.thestreet.com/p/newsanalysis/biotech/10538484_2.html
Get the latest RA - Railamerica Incorporated together with stock market performance data and financial news.
Get the latest RA - Railamerica Incorporated stock market performance data and financial news.
Read Jim Cramer's take on Railamerica Incorporated (RA) and get his latest thoughts on the company?s performance and outlook
An experimental pill from Incyte reduced symptoms in rheumatoid arthritis patients, according to results from a small phase II study presented Sunday.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10444436/1/incytes-rheumatoid-arthritis-pill-promising.html
Connect with TheStreet